A phase I clinical trial of S-1 in combination with sorafenib for patients with advanced hepatocellular carcinoma

被引：0
|
作者：
Yi, J.
Ahn, H.
Lee, S.
Uhm, J.
Lee, J.
Park, S.
Park, J.
Park, Y.
Lim, H.
Kang, W.
机构：
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea
[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Hematol Oncol, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.e14655
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14655
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Phase I clinical trial of continuous infusion of tyroserleutide in patients with advanced hepatocellular carcinoma
    Zhen-Yu Xiao
    Jin-Bin Jia
    Lin Chen
    Wei Zou
    Xiao-Ping Chen
    Medical Oncology, 2012, 29 : 1850 - 1858
  • [42] Phase I Study of Sorafenib and Vorinostat in Advanced Hepatocellular Carcinoma
    Gordon, Sarah W.
    McGuire, William P., III
    Shafer, Danielle A.
    Sterling, Richard K.
    Lee, Hannah M.
    Matherly, Scott C.
    Roberts, John D.
    Bose, Prithviraj
    Tombes, Mary B.
    Shrader, E. Ellen
    Ryan, Alison A.
    Kmieciak, Maciej
    Tri Nguyen
    Deng, Xiaoyan
    Bandyopadhyay, Dipankar
    Dent, Paul
    Poklepovic, Andrew S.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2019, 42 (08): : 649 - 654
  • [43] Phase I Study of Sorafenib and SBRT for Advanced Hepatocellular Carcinoma
    Dawson, L. A.
    Brade, A.
    Cho, C.
    Kim, J.
    Brierley, J.
    Dinniwell, R.
    Wong, R.
    Ringash, J.
    Cummings, B.
    Knox, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S10 - S11
  • [44] S-1 versus placebo in patients with sorafenib-refractory advanced hepatocellular carcinoma (S-CUBE): a randomised, double-blind, multicentre, phase 3 trial
    Kudo, Masatoshi
    Moriguchi, Michihisa
    Numata, Kazushi
    Hidaka, Hisashi
    Tanaka, Hironori
    Ikeda, Masafumi
    Kawazoe, Seiji
    Ohkawa, Shinichi
    Sato, Yozo
    Kaneko, Shuichi
    Furuse, Junji
    Takeuchi, Madoka
    Fang, Xuemin
    Date, Yoshito
    Takeuchi, Masahiro
    Okusaka, Takuji
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2017, 2 (06): : 407 - 417
  • [45] PHASE I TRIAL OF ERIBULIN/S-1 COMBINATION THERAPY FOR ADVANCED/RECURRENT BREAST CANCER
    Iwasa, Tsutomu
    Sakiyama, Tsutomu
    Tsurutani, Junji
    Tanaka, Kaoru
    Yoshida, Takeshi
    Nonagase, Yoshikane
    Fujisaka, Yasuhito
    Kurata, Takayasu
    Komoike, Yoshifumi
    Nakagawa, Kazuhiko
    ANNALS OF ONCOLOGY, 2014, 25
  • [46] Phase I trial of chemoradiotherapy with the combination of S-1 plus cisplatin for patients with unresectable locally advanced squamous cell carcinoma of the head and neck
    Tahara, Makoto
    Minami, Hironobu
    Kawashima, Mitsuhiko
    Kawada, Kenji
    Mukai, Hirofumi
    Sakuraba, Minoru
    Matsuura, Kazuto
    Ogino, Takashi
    Hayashi, Ryuichi
    Ohtsu, Atsushi
    CANCER SCIENCE, 2011, 102 (02) : 419 - 424
  • [47] Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial
    Bruix, Jordi
    Raoul, Jean-Luc
    Sherman, Morris
    Mazzaferro, Vincenzo
    Bolondi, Luigi
    Craxi, Antonio
    Galle, Peter R.
    Santoro, Armando
    Beaugrand, Michel
    Sangiovanni, Angelo
    Porta, Camillo
    Gerken, Guido
    Marrero, Jorge A.
    Nadel, Andrea
    Shan, Michael
    Moscovici, Marius
    Voliotis, Dimitris
    Llovet, Josep M.
    JOURNAL OF HEPATOLOGY, 2012, 57 (04) : 821 - 829
  • [48] Phase III trial of linifanib versus sorafenib in patients with advanced hepatocellular carcinoma (HCC)
    Cainap, Calin
    Qin, Shukui
    Huang, Wen-Tsung
    Chung, Ik-Joo
    Pan, Hongming
    Cheng, Ying
    Kudo, Masatoshi
    Kang, Yoon-Koo
    Chen, Pei-Jer
    Toh, Han Chong
    Gorbunova, Vera
    Eskens, Ferry
    Qian, Jiang
    McKee, Mark D.
    Ricker, Justin L.
    Carlson, Dawn M.
    El Nowiem, Saied
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [49] A Phase II Randomized Dose Escalation Trial of Sorafenib in Patients With Advanced Hepatocellular Carcinoma
    Rimassa, Lorenza
    Pressiani, Tiziana
    Boni, Corrado
    Carnaghi, Carlo
    Caremoli, Elena Rota
    Fagiuoli, Stefano
    Foa, Paolo
    Salvagni, Stefania
    Cortesi, Enrico
    Tronconi, Maria Chiara
    Personeni, Nicola
    Bozzarelli, Silvia
    Banzi, Maria Chiara
    Fanello, Silvia
    Lutman, Fabio Romano
    Giordano, Laura
    Santoro, Armando
    ONCOLOGIST, 2013, 18 (04): : 379 - 380
  • [50] Phase I multicenter trial of perifosine in combination with sorafenib for patients with advanced cancers including renal cell carcinoma
    Schreeder, M. T.
    Figlin, R. A.
    Stephenson, J. J.
    Campos, L.
    Chawla, S. P.
    Spigel, D. R.
    Spira, A.
    Sportelli, P.
    Gardner, L.
    Birch, R.
    Henderson, I. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345